Alphadyne Asset Management’s Gilead Sciences GILD Stock Holding History

Alphadyne Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.6M	Buy	140,700 +40,500	+40%	+$5.67M	0.34%	77
2025 Q4	$12.3M	Buy	+100,200	New	+$12.2M	0.29%	50

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Alphadyne Asset Management's GILD Position: Q1 2026 in Review

Alphadyne Asset Management opened a new position in Gilead Sciences (GILD) in Q1 2026: 45,108 shares worth $6.29M. The stake represents 0.11% of the portfolio and ranks #256 among its holdings.

2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Alphadyne Asset Management held 45,108 shares of Gilead Sciences worth $6.29M as of Q1 2026.
Gilead Sciences was a new Alphadyne Asset Management position in Q1 2026.
Gilead Sciences made up 0.11% of Alphadyne Asset Management's portfolio in Q1 2026, its #256 holding.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Alphadyne Asset Management's 13F filing for Q1 2026, filed 15 May 2026.